- Home
- PEB vs ELVN Comparison
PEB vs ELVN Comparison
Compare PEB & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEB
- ELVN
- Stock Information
- Founded
- PEB 2009
- ELVN 2016
- Country
- PEB United States
- ELVN United States
- Employees
- PEB N/A
- ELVN N/A
- Industry
- PEB Real Estate Investment Trusts
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- PEB Real Estate
- ELVN Health Care
- Exchange
- PEB Nasdaq
- ELVN Nasdaq
- Market Cap
- PEB 1.2B
- ELVN 1.2B
- IPO Year
- PEB 2009
- ELVN 2020
- Fundamental
- Price
- PEB $9.84
- ELVN $19.12
- Analyst Decision
- PEB Hold
- ELVN Strong Buy
- Analyst Count
- PEB 7
- ELVN 5
- Target Price
- PEB $11.83
- ELVN $41.20
- AVG Volume (30 Days)
- PEB 2.3M
- ELVN 393.8K
- Earning Date
- PEB 07-29-2025
- ELVN 08-12-2025
- Dividend Yield
- PEB 0.40%
- ELVN N/A
- EPS Growth
- PEB N/A
- ELVN N/A
- EPS
- PEB N/A
- ELVN N/A
- Revenue
- PEB $1,469,933,000.00
- ELVN N/A
- Revenue This Year
- PEB $1.70
- ELVN N/A
- Revenue Next Year
- PEB $2.84
- ELVN N/A
- P/E Ratio
- PEB N/A
- ELVN N/A
- Revenue Growth
- PEB 2.00
- ELVN N/A
- 52 Week Low
- PEB $7.42
- ELVN $13.30
- 52 Week High
- PEB $15.12
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- PEB 41.88
- ELVN 41.23
- Support Level
- PEB $9.52
- ELVN $18.18
- Resistance Level
- PEB $11.21
- ELVN $19.33
- Average True Range (ATR)
- PEB 0.38
- ELVN 1.16
- MACD
- PEB -0.13
- ELVN -0.34
- Stochastic Oscillator
- PEB 19.82
- ELVN 15.08
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.